Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.18
+0.03 (0.49%)
At close: Nov 14, 2025, 4:00 PM EST
6.06
-0.12 (-1.94%)
After-hours: Nov 14, 2025, 5:23 PM EST
Kezar Life Sciences Market Cap
Kezar Life Sciences has a market cap or net worth of $45.26 million as of November 14, 2025. Its market cap has decreased by -24.26% in one year.
Market Cap
45.26M
Enterprise Value
-35.05M
1-Year Change
-24.26%
Ranking
Category
Stock Price
$6.18
Market Cap Chart
Since June 21, 2018, Kezar Life Sciences's market cap has decreased from $325.21M to $45.26M, a decrease of -86.08%. That is a compound annual growth rate of -23.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 45.26M | -7.70% |
| Dec 31, 2024 | 49.03M | -28.81% |
| Dec 29, 2023 | 68.87M | -85.69% |
| Dec 30, 2022 | 481.38M | -41.42% |
| Dec 31, 2021 | 821.73M | 240.23% |
| Dec 31, 2020 | 241.52M | 214.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 911.30B |
| Johnson & Johnson | 468.34B |
| AbbVie | 412.21B |
| UnitedHealth Group | 307.13B |
| AstraZeneca | 275.24B |
| Novartis AG | 251.93B |
| Merck & Co. | 226.98B |
| Abbott Laboratories | 224.00B |